Email Updates

You are here

Home

9 NOVEMBER 2018 VOLUME 19 ISSUE 45

Media Coverage

  • Vaccine still kicking

    HIV vaccine regimens continued to show immune responses in monkeys and humans up to a year after the last vaccination, according to results presented at AIDS 2018 in Amsterdam. The vaccine in this study is called a mosaic-based vaccine because it contains various components that are designed to bring about immune responses against many different HIV strains.

    November 9, 2018
    HIV Vaccine
    Positively Aware

  • Fake News, Real Consequences: What happens after headlines about false HIV 'cures'

    Fake news about HIV cures gives false hope to those living with HIV and even threatens to reverse some of the good work currently being done in the battle against the virus.

    November 9, 2018
    Cure, General
    Bhekisisa

  • Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

    A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25 percent lower than those in cisgender men, and levels in rectal tissue cells about 40 percent lower. Tenofovir levels in rectal tissue were 44 percent lower.

    November 9, 2018
    PrEP
    aidsmap

  • More women on HIV treatment in Nigeria

    Some seven hundred and forty-seven thousand, eight hundred and fifty-three females were among the 1,090,233 people on anti-retroviral treatment in Nigeria by June, National Agency for the Control of HIV/AIDS, says.

    November 9, 2018
    Treatment
    Punch Nigeria

  • Night time HIV testing a hit in Masvingo, Zimbabwe

    NAC Masvingo Provincial Manager, Mr Edgar Muzulu, told journalists on a tour of the province last week that the the night HIV testing was meant to benefit sex workers, truck drivers and artisanal miners who normally shied away from health services.

    November 8, 2018
    General
    Chronicle

  • Rural telehealth programs help prevent HIV

    Keeping patients on pre-exposure prophylaxis (PrEP) for HIV prevention is always a challenge, but in rural parts of the country, it can be nearly impossible, said Donna McGregor, NP, from the University of Colorado School of Medicine in Aurora.

    November 8, 2018
    PrEP
    Medscape

  • Why women are more prone to HIV infection

    In Uganda, about 1.5 million people are living with HIV/AIDS, but an analysis of data shows that new infections are more in females than males. For instance, in 2015, it was estimated that 567 young people aged between 15-24 years get infected with HIV every week and of these, 363 were girls. A 2016 report shows that 570 young women aged 15-24 years got infected with HIV every week in Uganda.

    November 8, 2018
    General
    New Vision

  • Federal government contributes only 5.4 percent of Nigeria’s HIV funding

    Disclosing this at a media dialogue on Prevention of Mother-To-Child Transmission (PMTCT), held in Calabar, Olugbenga Ijaodola, Assistant Director, PMTCT and Head, National AIDS and STI Programme of the Ministry (NASCP) said the U.S. Government was responsible for 75.5 percent of treatment interventions, while Global Fund accounted for 17.4 percent, AIDS Healthcare Foundation (AHF) 1.2 percent and Nigerian Government 5.4 percent.

    November 7, 2018
    General
    TV 360

  • Why Almost No One in Nigeria is Using HIV Prevention Drugs

    In Nigeria, more than 3 million people are living with HIV, but less than 400 people at the highest risk of infection are using PrEP, widely regarded as a key tool in the battle against the disease’s spread.

    November 7, 2018
    PrEP
    Devex

  • Uganda recruits women for new trial in injectable HIV drug

    The trial, known as HPTN084, will examine whether the drug cabotegravir injected once every eight weeks can safely protect women at risk of HIV infection.

    November 7, 2018
    Treatment
    The East African

  • PrEP sorting: HIV negative gay men prefer sexual partners who are using PrEP

    PrEP status is a significant factor for HIV negative men who have sex with men (MSM) when selecting sexual partners, but not when choosing friends or romantic partners for dating, according to an American study published in AIDS Care.

    November 7, 2018
    PrEP
    aidsmap

  • Fostemsavir, novel gp120 inhibitor, salvages nearly half of people with no other treatment options left

    The recent International Congress on Drug Therapy in HIV Infection (HIV Glasgow) featured trials of several HIV drugs with modes of action different from the usual classes. Despite the overall success of antiretrovirals (ARVs), there remain a minority of people who, due to the development of intractable HIV drug resistance, still need what used to be called “salvage drugs”.

    November 7, 2018
    Treatment
    aidsmap

  • How has Glasgow responded to an outbreak of HIV among people who inject drugs?

    Intensive efforts to reach people who inject drugs who have acquired HIV in a recent transmission outbreak in the city have resulted in high levels of antiretroviral treatment and viral suppression in a predominantly homeless population, clinicians and nurse specialists from Glasgow’s Brownlee Centre for Infectious Diseases reported in a poster discussion session dedicated to the city’s response to the outbreak at HIV Glasgow 2018 last week.

    November 7, 2018
    Treatment
    aidsmap

  • When is a nation’s HIV epidemic considered “controlled”?

    Hitting the so-called 90-90-90 target would mean that 73 percent of a national HIV population would have an undetectable viral load. Thanks to the preventive power of HIV treatment—a huge body of research has indicated that such full suppression of the virus is associated with effectively zero chance of transmission—reaching this high rate of viral suppression, UNAIDS predicts, puts a nation at a crucial tipping point that would ultimately lead to epidemic control.

    November 7, 2018
    General
    POZ

  • New Vaginal Ring Holds Promise to Reduce HIV Risk

    A new long-acting vaginal ring that women themselves can insert into their own bodies is giving new hope to reducing the risk of HIV, according to a report at a recent HIV research conference in Madrid.

    November 7, 2018
    Microbicides
    Asia Sentinel

  • Gammora does not cure HIV

    An Israeli biotech company has issued a misleading press release which has encouraged some media outlets to falsely suggest that a new drug, Gammora, may be able to cure HIV.

    November 6, 2018
    Treatment
    aidsmap

  • Media urged to raise awareness level on prevention of Mother-To-Child transmission of HIV/AIDS

    The media and stakeholders in Nigeria have been charged to raise the awareness level on the prevention of Mother-To-Child transmission of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (HIV/AIDS) infection in the country.

    November 6, 2018
    General
    All Africa

  • FDA approves HIV test for use with VITROS 5600 integrated system

    The 4th generation test detects both HIV-1 and HIV-2 antibodies as well as the p24 antigen, which provides a shorter diagnostic window compared to 3rd generation assays.

    November 6, 2018
    General
    MD Magazine

  • India May Be on the Verge of Introducing PrEP to Combat HIV crisis

    The Indian Council of Medical Research (ICMR) has indicated it is planning to study the effectiveness of PrEP in high-risk groups. Those high risk groups include MSM and trans women.

    November 3, 2018
    PrEP
    Gay Star News

  • Pregnant women drop HIV pill over side effects

    “Despite all the efforts and resources that have gone into creating demand for the pill over the past year, the uptake and adherence remains poor,” said one of the Kenyan studies.

    November 3, 2018
    PrEP
    Standard Digital

  • HIV/AIDS pandemic lingers despite successes

    The prevalence rate has since dropped to around 6 percent. Uganda records about 50,000 new HIV infections annually currently, down from 150,000 in 2013. People dying from AIDS-related illnesses have also reduced by 73 percent; from 75,000 in the late 1980s and early 1990s, to 20,000 today.

    November 3, 2018
    Treatment
    New Vision

  • Malaysia eliminates HIV transmission from mother-to-child

    Malaysia becomes the first country in the Western Pacific region to eliminate mother-to-child transmission of both HIV and syphilis, officially validated by the World Health Organization (WHO) earlier in October.

    November 2, 2018
    General
    Avert

  • Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows

    Fifteen out of 40 people who started treatment with ibalizumab had a viral load below 50 copies/ml on a regimen optimised by resistance testing after 48 weeks of treatment, despite extensive resistance to antiretroviral drugs.

    November 2, 2018
    Treatment
    aidsmap

  • HIV/AIDS among youth up by 45 percent due to ‘risky sex’ – AIDS Commission

    The Ghana AIDS Commission says the prevalence of HIV/AIDS amongst the country’s youth in 2017, particularly those below the age of 24, rose to about 45 percent nationwide.

    November 2, 2018
    General
    Citi Newsroom

  • Stakeholders tackle road maps to HIV cure

    Representatives from 13 countries across Asia and the Pacific gathered in Bangkok, Thailand, from Oct. 29 to 31 to develop road maps to implement and expand pre-exposure prophylaxis and HIV self-testing in the region.

    November 1, 2018
    PrEP
    Manila Standard

  • Localities to strengthen HIV/AIDS control and prevention

    The Ministry of Health has asked provinces and cities to strengthen HIV/AIDS control and prevention activities as part of the Central Party Steering Committee’s goal of eliminating HIV/AIDS in the country by 2030.

    October 30, 2018
    General
    Viet Nam News

Published Research

Announcements